The role of supplemental coverage in a universal health insurance system: Some Canadian evidence.

OBJECTIVE To examine the effect of supplemental health insurance for prescription drug coverage on health care utilization as measured by the number of visits to physicians in a setting with incomplete public insurance coverage. METHODS A latent-class modeling approach is used to capture the presence of latent heterogeneity in the utilization of physician services. The insurance variable is grouped into three different types, depending upon how it is provided - by government, employers, or private companies. The data for this study come from the Ontario component of the Canadian Community Health Survey 2005, a representative sample of the Ontario population, conducted by Statistics Canada. RESULTS We find that physician health care utilization responds to the presence and type of insurance, and that the results vary substantially across different types of individuals based on unobservable health status characterized by two latent classes: low users (healthy) and high users (less healthy). CONCLUSIONS The fact that not all individuals have access to supplemental insurance for prescription drug coverage calls into question the universality of public insurance that does not cover important complementary services, such as outpatient prescription drugs.

[1]  Catherine E. Déri.  Social networks and health service utilization. , 2005, Journal of health economics.

[2]  S. Birch,et al.  Equity in health care: methodological contributions to the analysis of hospital utilization within Canada. , 1995, Social science & medicine.

[3]  Ricardo Andres Henriquez Höfter.  Private health insurance and utilization of health services in Chile , 2006 .

[4]  S. Birch,et al.  Equitable access to health care: methodological extensions to the analysis of physician utilization in Canada. , 1993, Health economics.

[5]  S. H. Long,et al.  Acute health care costs for the aged Medicare population: overview and policy options. , 1987, The Milbank quarterly.

[6]  M. Solomon,et al.  Benefits and the Use of Drugs by the Chronically Ill , 2004 .

[7]  T. Buchmueller,et al.  Access to Physician Services: Does Supplemental Insurance Matter? Evidence from France , 2002, Health economics.

[8]  Amy N. Finkelstein,et al.  The Interaction of Partial Public Insurance Programs and Residual Private Insurance Markets: Evidence from the U.S. Medicare Program , 2002, Journal of health economics.

[9]  M. Stano,et al.  The Economics of Health and Health Care , 1993 .

[10]  Steffie Woolhandler,et al.  Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. , 2006, American journal of public health.

[11]  S. Teutsch,et al.  Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. , 2005, The American journal of managed care.

[12]  R. Winkelmann.  Co-payments for prescription drugs and the demand for doctor visits--evidence from a natural experiment. , 2004, Health economics.

[13]  Partha Deb,et al.  The structure of demand for health care: latent class versus two-part models. , 2002, Journal of health economics.

[14]  J. Tu,et al.  Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures , 2008, Canadian Medical Association Journal.

[15]  A. Leibowitz.  Substitution Between Prescribed and Over-the-Counter Medications , 1989, Medical care.

[16]  K. Basu,et al.  The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada. , 2007, Social science & medicine.

[17]  Xin Li,et al.  The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. , 2007, Health policy.

[18]  W. Manning,et al.  Moral Hazard and Consumer Incentives in Health Care , 2000 .

[19]  S. Kennedy,et al.  Insights into the 'healthy immigrant effect': health status and health service use of immigrants to Canada. , 2004, Social science & medicine.

[20]  L. Curtis,et al.  Health Care Utilization in Canada: Twenty-five Years of Evidence , 2008 .

[21]  J. Nyman,et al.  The value of health insurance: the access motive. , 1999, Journal of health economics.

[22]  M. Stabile.  Private insurance subsidies and public health care markets: evidence from Canada , 2001 .

[23]  W. Simpson,et al.  A microeconometric analysis of Canadian health care utilization. , 2006, Health economics.

[24]  B. Stuart,et al.  Are Prescribed and Over‐the-Counter Medicines Economic Substitutes?: A Study of the Effects of Health Insurance on Medicine Choices by the Elderly , 1995, Medical care.

[25]  C. Huttin.  The role of different types of health insurance on access and utilization: comparative results on two chronic conditions (hypertension and diabetes type II without complication) , 2007 .

[26]  J. Hurley,et al.  Inequity in publicly funded physician care: what is the role of private prescription drug insurance? , 2009, Health economics.

[27]  Pravin K. Trivedi,et al.  Regression Analysis of Count Data , 1998 .

[28]  K. Grumbach,et al.  Book Review: The Effect of Health Insurance on Medical Care Utilization and Implications for Insurance Expansion: A Review of the Literature , 2005, Medical care research and review : MCRR.